Nabriva Therapeutics PLC NBRVF
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.25 / $0.51
- Shares Outstanding
- 3.23M
- Market Cap
- $323.08
- Volume/Avg
- 484 / 430
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. The company is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company has developed a product candidate, XENLETA, a semi-synthetic pleuromutilin antibiotic that is the first in its class for oral and IV administration in humans. The firm has commercial rights to two approved products, SIVEXTRO and XENLETA, as well as one development product candidate, CONTEPO.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 39
- Website
- https://www.nabriva.com
Valuation
|
Metric
|
NBRVF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NBRVF
|
|---|---|
Quick Ratio | 0.25 |
Current Ratio | 0.38 |
Interest Coverage | −112.20 |
Quick Ratio
NBRVF
Profitability
|
Metric
|
NBRVF
|
|---|---|
Return on Assets (Normalized) | −157.64% |
Return on Equity (Normalized) | −624.84% |
Return on Invested Capital (Normalized) | −425.55% |
Return on Assets
NBRVF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|t<^$DP^ | LOCK|$F><h | $126B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|$!pL<Lw | LOCK|>&#kQ | $81B | |||
| argenx SE ADR
ARGX
| LOCK|L$&VYX | LOCK|@!J | $55B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|b<Qs>L% | LOCK|JhGp% | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|L@!mfH | LOCK|p@ | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|q!t><j$ | LOCK|^f!$# | $29B | |||
| Incyte Corp
INCY
| LOCK|h<lc^z! | LOCK|@%? | $24B | |||
| Moderna Inc
MRNA
| LOCK|yxYx$^y | LOCK|&! | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|xPjLq$ | LOCK|S?k | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|#%j!?#? | LOCK|t? | $17B |
United States